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Summary {#efs25251-sec-0001}
=======

Asulam was an existing active substance for which EFSA organised a peer review of the initial evaluation, i.e. the draft assessment report (DAR), provided by the United Kingdom being the designated rapporteur Member State (RMS). The peer review process was subsequently terminated following the applicant\'s decision, to withdraw support for the inclusion of asulam in Annex I to Council Directive 91/414/EEC. Following the Commission Decision 2008/934/EC of 5 December 2008 concerning the non‐inclusion of asulam in Annex I to Council Directive 91/414/EEC and the withdrawal of authorisations for plant protection products containing that substance, the applicant United Phosphorus Ltd. made a resubmission application for the inclusion of asulam in Annex I in accordance with the provisions laid down in Commission Regulation (EC) No 33/2008. Following the peer review of the additional data (EFSA, [2010](#efs25251-bib-0004){ref-type="ref"}), a non‐approval was granted under Commission Implementing Regulation (EU) No 1045/2011.

In accordance with Article 7 of Regulation (EC) No 1107/2009 of the European Parliament and of the Council (hereinafter referred to as 'the Regulation'), the rapporteur Member State (RMS), the United Kingdom, received an application from UPL Europe Limited on 19 December 2013 for the approval of the active substance asulam‐sodium. In accordance with Article 8(1)(g) of the Regulation, UPL Europe Limited submitted applications for maximum residue levels (MRLs) as referred to in Article 7 of Regulation (EC) No 396/2005. Complying with Article 9 of the Regulation, the completeness of the dossier was checked by the RMS and the date of admissibility of the application was recognised as being 30 June 2014.

The RMS provided its initial evaluation of the dossier on asulam‐sodium in the draft assessment report (DAR), which was received by the European Food Safety Authority (EFSA) on 21 April 2016. The DAR included a proposal to set MRLs, in accordance with Article 11(2) of the Regulation. The peer review was initiated on 6 July 2016 by dispatching the DAR for consultation to the Member States and the applicant, UPL Europe Limited.

Following consideration of the comments received on the DAR, it was concluded that additional information should be requested from the applicant and that EFSA should conduct an expert consultation in the areas of mammalian toxicology, residues and ecotoxicology. It became apparent during the Peer Review experts\' meeting on residues that there is a need to obtain more information on several metabolites, which were identified in new metabolism studies, beyond what was available in the RMS\'s assessment report. The RMS was requested to provide a revised DAR for the sections on mammalian toxicology and residues. After the submission of the revised DAR in November 2017, EFSA organised a written commenting round with the Member States and following that an ad hoc expert consultation in the areas of mammalian toxicology and residues.

In accordance with Article 12 of the Regulation, EFSA should adopt a conclusion on whether asulam (variant evaluated asulam‐sodium) can be expected to meet the approval criteria provided for in Article 4 of the Regulation taking into consideration recital (10) of the Regulation and give a reasoned opinion concerning MRL applications, as referred to in Article 10(1) of Regulation (EC) No 396/2005. Furthermore, this conclusion also addresses the assessment required from EFSA under Article 12 of Regulation (EC) No 396/2005, provided the active substance will be approved under Regulation (EC) No 1107/2009 without restrictions affecting the residue assessment.

The conclusions laid down in this report were reached on the basis of the evaluation of the representative uses of asulam (variant evaluated asulam‐sodium) as a herbicide on spinach and tulip, hyacinth and lily for bulb production, as proposed by the applicant. MRLs were assessed in spinach. Full details of the representative uses and the proposed MRLs can be found in Appendix [A](#efs25251-sec-1002){ref-type="sec"} of this report.

The uses of asulam‐sodium according to the representative uses proposed at European Union (EU) level result in a sufficient herbicidal efficacy against the target weeds.

In the area of identity, physical and chemical properties and analytical methods, data gaps were identified for additional validation data for the residue monitoring method for plants, including its independent laboratory validation.

In the area of mammalian toxicology and non‐dietary exposure, further data are needed to conclude on the human relevance of the thyroid toxicity observed in test species exposed to asulam; the outcome of which may require further consideration in terms of endocrine disrupting potential despite the interim criteria not being met. Data gaps are identified concerning the available genotoxicity studies, the developmental thyroid toxicity studies and dermal toxicity studies.

In the area of residues, data gaps were identified for additional residue data in processed spinach commodities, information to validate the residue levels in the available processing trials regarding storage stability, and data on residues in rotational crops. These requirements are mostly affecting the finalisation of a robust consumer risk assessment for sulfanilamide and related compounds which are considered of higher potency than asulam.

The data available on environmental fate and behaviour are sufficient to carry out the required environmental exposure assessments at EU level for the representative uses, with the notable exception that information is missing regarding the effect of water treatment processes on the nature of the residues that might be present in surface water, when surface water is abstracted for drinking water. Consequently, the consumer risk assessment from the consumption of drinking water could not be finalised. The potential for groundwater exposure above the parametric drinking water limit of 0.1 μg/L consequent to the uses assessed, was assessed as low for asulam and its salts and its soil metabolite sulfanilamide identified as triggering a groundwater exposure assessment, in geoclimatic situations represented by all seven pertinent FOCUS groundwater scenarios.

In the area of ecotoxicology, a data gap was identified to address the long‐term risk to soil organisms from non‐extractable soil residues (issue that could not be finalised). The long‐term risk to birds and wild mammals was identified as a data gap and critical area of concern. In addition, due to high risk to aquatic organisms, a data gap was identified for the R4 FOCUS surface water scenario for the representative use for spinach.

Background {#efs25251-sec-0003}
==========

Regulation (EC) No 1107/2009 of the European Parliament and of the Council[1](#efs25251-note-2004){ref-type="fn"} (hereinafter referred to as 'the Regulation') lays down, *inter alia*, the detailed rules as regards the procedure and conditions for approval of active substances. This regulates for the European Food Safety Authority (EFSA) the procedure for organising the consultation of Member States and the applicant(s) for comments on the initial evaluation in the draft assessment report (DAR), provided by the rapporteur Member State (RMS), and the organisation of an expert consultation, where appropriate.

In accordance with Article 12 of the Regulation, EFSA is required to adopt a conclusion on whether an active substance can be expected to meet the approval criteria provided for in Article 4 of the Regulation (also taking into consideration recital (10) of the Regulation) within 120 days from the end of the period provided for the submission of written comments, subject to an extension of 30 days where an expert consultation is necessary, and a further extension of up to 150 days where additional information is required to be submitted by the applicant(s) in accordance with Article 12(3).

Asulam was an existing active substance for which the EFSA organised a peer review of the initial evaluation, i.e. the draft assessment report (DAR), provided by the United Kingdom being the designated rapporteur Member State (RMS). The peer review process was subsequently terminated following the applicant\'s decision, to withdraw support for the inclusion of asulam in Annex I to Council Directive 91/414/EEC.[2](#efs25251-note-2005){ref-type="fn"} Following the Commission Decision 2008/934/EC[3](#efs25251-note-2006){ref-type="fn"} of 5 December 2008 concerning the non‐inclusion of asulam in Annex I to Council Directive 91/414/EEC and the withdrawal of authorisations for plant protection products containing that substance, the applicant UPL Europe Limited made a resubmission application for the inclusion of asulam in Annex I in accordance with the provisions laid down in Commission Regulation (EC) No 33/2008[4](#efs25251-note-1004){ref-type="fn"}. Following the peer review of the additional data (EFSA, [2010](#efs25251-bib-0004){ref-type="ref"}) a non‐approval was granted under Commission Implementing Regulation (EU) No 1045/2011[5](#efs25251-note-1005){ref-type="fn"}.

The RMS, the United Kingdom (hereinafter referred to as the 'RMS'), in accordance with Article 7 of the Regulation, received an application from UPL Europe Limited on 19 December 2013 for a new approval of the active substance asulam‐sodium. In accordance with Article 8(1)(g) of the Regulation, UPL Europe Limited submitted applications for maximum residue levels (MRLs) as referred to in Article 7 of Regulation (EC) No 396/2005[6](#efs25251-note-1006){ref-type="fn"}. Complying with Article 9 of the Regulation, the completeness of the dossier was checked by the RMS and the date of admissibility of the application was recognised as being 30 June 2014.

The RMS provided its initial evaluation of the dossier on asulam‐sodium in the DAR, which was received by EFSA on 21 April 2016 (United Kingdom, [2016](#efs25251-bib-0025){ref-type="ref"}). The DAR included a proposal to set MRLs, in accordance with Article 11(2) of the Regulation. The peer review was initiated on 6 July 2016 by dispatching the DAR for consultation of the Member States and the applicant, UPL Europe Limited, for consultation and comments. EFSA also provided comments. In addition, EFSA conducted a public consultation on the DAR. The comments received were collated by EFSA and forwarded to the RMS for compilation and evaluation in the format of a reporting table. The applicant was invited to respond to the comments in column 3 of the reporting table. The comments and the applicant response were evaluated by the RMS in column 3.

The need for expert consultation and the necessity for additional information to be submitted by the applicant in accordance with Article 12(3) of the Regulation were considered in a telephone conference between EFSA, the RMS, the European Commission and the European Chemicals Agency (ECHA) on 24 October 2016. On the basis of the comments received, the applicant\'s response to the comments and the RMS\'s evaluation thereof, it was concluded that additional information should be requested from the applicant and that EFSA should conduct an expert consultation in the areas of mammalian toxicology, residues and ecotoxicology.

The outcome of the telephone conference, together with EFSA\'s further consideration of the comments is reflected in the conclusions set out in column 4 of the reporting table. All points that were identified as unresolved at the end of the comment evaluation phase and which required further consideration, including those issues to be considered in an expert consultation, were compiled by EFSA in the format of an evaluation table.

The conclusions arising from the consideration by EFSA, and as appropriate by the RMS, of the points identified in the evaluation table, together with the outcome of the expert consultation where this took place, were reported in the final column of the evaluation table.

It became apparent during the Peer Review experts\' meeting on residues that there is a need to obtain more information on several metabolites, which were identified in new metabolism studies, beyond what was available in the RMS\'s assessment report. The RMS agreed to provide a revision of the DAR for the sections on mammalian toxicology and residues in order to address the outstanding issues and to provide a comprehensive assessment of the additional information submitted by the applicant following a request from EFSA in accordance with Art. 12(3) of the Regulation. The RMS submitted the revised DAR in November 2017. After the submission of the revised DAR EFSA organised a written commenting round with the Member States and following that an ad hoc expert consultation in the areas of mammalian toxicology and residues.

In accordance with Article 12 of the Regulation, EFSA should adopt a conclusion on whether asulam can be expected to meet the approval criteria provided for in Article 4 of the Regulation, taking into consideration recital (10) of the Regulation, and give a reasoned opinion concerning MRL applications as referred to in Article 10(1) of Regulation (EC) No 396/2005. A final consultation on the conclusions arising from the peer review of the risk assessment and on the proposed MRLs took place with Member States via a written procedure in March 2018.

This conclusion report summarises the outcome of the peer review of the risk assessment on the active substance and the representative formulation evaluated on the basis of the representative use of asulam (variant evaluated asulam‐sodium) as a herbicide on spinach and tulip, hyacinth and lily for bulb production, as proposed by the applicant. MRLs were assessed in spinach. Furthermore, this conclusion also addresses the assessment required from EFSA under Article 12 of Regulation (EC) No 396/2005, provided the active substance will be approved under Regulation (EC) No 1107/2009 without restrictions affecting the residue assessment. In the event of a non‐approval of the active substance or an approval with restrictions that have an impact on the residue assessment, the MRL proposals from this conclusion might no longer be relevant and a new assessment under Article 12 of Regulation (EC) No 396/2005 will be required. A list of the relevant end points for the active substance and the formulation and the proposed MRLs is provided in Appendix [A](#efs25251-sec-1002){ref-type="sec"}.

In addition, a key supporting document to this conclusion is the peer review report (EFSA, [2018](#efs25251-bib-0005){ref-type="ref"}), which is a compilation of the documentation developed to evaluate and address all issues raised in the peer review, from the initial commenting phase to the conclusion. The peer review report comprises the following documents, in which all views expressed during the course of the peer review, including minority views where applicable, can be found: the comments received on the DAR;the reporting table (24 October 2016);the evaluation table (27 March 2018);the report(s) of the scientific consultation with Member State experts (where relevant);the comments received on the assessment of the additional information (where relevant);the comments received on the draft EFSA conclusion.

Given the importance of the DAR including its revisions (United Kingdom, [2018](#efs25251-bib-0026){ref-type="ref"}) and the peer review report, both documents are considered as background documents to this conclusion.

It is recommended that this conclusion report and its background documents would not be accepted to support any registration outside the European Union (EU) for which the applicant has not demonstrated that it has regulatory access to the information on which this conclusion report is based.

The active substance and the formulated product {#efs25251-sec-0004}
===============================================

Asulam is the ISO common name for methyl sulfanilylcarbamate (IUPAC). Asulam‐sodium is the modified ISO common name for sodium \[(4‐aminophenyl)sulfonyl\](methoxycarbonyl)azanide (IUPAC), a derivative of asulam.

The representative formulated product for the evaluation was 'Asulox', a soluble concentrate (SL) containing 438 g/L asulam‐sodium (equivalent to 400 g/L asulam).

The representative uses evaluated were foliar spray applications in spinach and tulip, hyacinth and lily for bulb production to control broadleaved weeds and grass weeds. Full details of the Good Agricultural Practices (GAPs) can be found in the list of end points in Appendix [A](#efs25251-sec-1002){ref-type="sec"}.

Data were submitted to conclude that the uses of asulam‐sodium according to the representative uses proposed at EU level result in a sufficient herbicidal efficacy against the target weeds following the guidance document SANCO/2012/11251‐rev. 4 (European Commission, [2014](#efs25251-bib-0016){ref-type="ref"}).

Conclusions of the evaluation {#efs25251-sec-0005}
=============================

1. Identity, physical/chemical/technical properties and methods of analysis {#efs25251-sec-0006}
===========================================================================

The following guidance documents were followed in the production of this conclusion: SANCO/3029/99‐rev. 4 (European Commission, [2000a](#efs25251-bib-0008){ref-type="ref"}), SANCO/3030/99‐rev. 4 (European Commission, [2000b](#efs25251-bib-0009){ref-type="ref"}), SANCO/825/00‐rev. 8.1 (European Commission, [2010](#efs25251-bib-0013){ref-type="ref"}).

Asulam‐sodium is produced as a technical concentrate (TK). The proposed specification is based on batch data from industrial scale production. The proposed specification range for the TK is 390--430 g/kg asulam‐sodium. The minimum purity of the technical material on dry weight basis is 876 g/kg asulam‐sodium, equivalent to 800 g/kg of asulam. The minimum purity is meeting the requirements of the FAO specification AGP:CP/353 (1998) for the technical material (TC) of minimum 800 g/kg asulam, equivalent to 876 g/kg asulam‐sodium, developed under the old procedure. Methanol was considered relevant impurity with the maximum amount of 25 g/kg (on dry weight basis) (See Section [2](#efs25251-sec-0007){ref-type="sec"}).

The assessment of the data package revealed no issues that need to be included as critical areas of concern with respect to the identity, physical, chemical and technical properties of asulam‐sodium or the representative formulation. The main data regarding the identity of asulam‐sodium and its physical and chemical properties are given in Appendix [A](#efs25251-sec-1002){ref-type="sec"}.

Adequate methods are available for the determination of the active substance and the relevant impurity methanol in the technical material and in the representative formulation.

Residues of asulam and its metabolite malonyl‐asulam in food and feed of plants origin can be determined by liquid chromatography with tandem mass spectrometry (LC--MS/MS) with a limit of quantification (LOQ) of 0.1 mg/kg asulam plus its metabolite malonyl‐asulam expressed as asulam, in all commodity groups. Data gaps were, however, identified for the revalidation of the method proposed as the monitoring method for the four crop groups using three extraction steps, and as a consequence, the corresponding update of the independent laboratory validation (ILV) for this method.

Pending on the final residue definition in food and feed of animal origin a monitoring method might be needed.

An appropriate LC--MS/MS method exists for monitoring the residues of asulam in soil with a LOQ of 0.005 mg/kg. An adequate LC--MS/MS method was available for the determination of residues of asulam and its metabolite sulfanilamide in water with a LOQ of 0.05 μg/L for each compound. Asulam residues in air can be determined by LC--MS/MS with a LOQ of 10 μg/m^3^.

2. Mammalian toxicity {#efs25251-sec-0007}
=====================

The toxicological profile of the active substance asulam and its metabolites was discussed at the Pesticides Peer Review Experts\' Meeting 140 and the Peer Review Teleconference 162a and assessed based on the following guidance documents: SANCO/221/2000‐rev. 10‐final (European Commission, [2003](#efs25251-bib-0012){ref-type="ref"}), SANCO/10597/2003‐rev. 10.1 (European Commission, [2012](#efs25251-bib-0015){ref-type="ref"}), Guidance on Dermal Absorption (EFSA PPR Panel, [2012](#efs25251-bib-0006){ref-type="ref"}) and Guidance on the Application of the CLP Criteria (ECHA, [2015](#efs25251-bib-0001){ref-type="ref"}).

The applicant submitted a set of valid toxicity studies on asulam or asulam‐sodium according to Regulation (EC) 544/2011[7](#efs25251-note-1007){ref-type="fn"} to assess the toxicological profile of asulam. The batches used in toxicity studies were representative of the proposed technical specification for the active substance and associated impurities (see Section [1](#efs25251-sec-0006){ref-type="sec"}). Regarding impurities, methanol was considered a relevant impurity (maximum content 2.5%). Asulam and asulam‐sodium are considered toxicologically equivalent.

In the toxicokinetic studies, asulam was extensively and rapidly absorbed. Oral absorption was estimated to be greater than 80%.

In the acute toxicity studies, the substance has low acute toxicity when administered orally, dermally or by inhalation to rats. It is not a skin or eye irritant but a skin sensitiser.

After repeated oral short‐term and long‐term exposure, the target organs included blood (rat, mouse), kidney and the adrenal (rat), and the thyroid (rat, dog). The relevant short‐term oral no observed adverse effect level (NOAEL) is 100 mg/kg body weight (bw) per day (dog studies), whereas the relevant long‐term NOAEL is 36 mg/kg bw per day (2‐year rat). The applicant informed the RMS that a new dermal toxicity study is available but it cannot be taken into account during the peer review process (data gap).[8](#efs25251-note-1008){ref-type="fn"}

The experts discussed the genotoxic potential of asulam. The in vivo micronucleus test gave ambiguous results. The study was performed using the intraperitoneal (i.p.) route and at a higher dose level than the limit dose recommended according to the OECD guideline. The applicant submitted an additional Ames test and chromosome aberration tests with asulam and they were both negative. Asulam and asulam‐sodium are considered equivalent and unlikely to be genotoxic. The new *in vitro* chromosome aberration test can be considered acceptable and showed negative[9](#efs25251-note-1009){ref-type="fn"} results. In the previous *in vitro* chromosome aberration test, some concerns were raised on the acceptability of the test. It was also noted that the positive response in one of the *in vitro* mouse lymphoma assays (MLA) was observed at a higher dose level than the top dose level recommended in the gene mutation assay. All the experts agreed that no concerns are present regarding the *in vitro* data. Some experts indicated that a new *in vivo* test should be requested considering also that chronic and carcinogenicity studies in rats showed limitations (high mortality). Some experts expressed the opinion that a new *in vivo* micronucleus test should be performed using the oral route at the limit dose of 2,000 mg/kg bw. A slight majority of experts agreed with RMS that no further studies should be required, while two experts disagreed and considered that an additional *in vivo* test should be performed. During the peer review, the applicant informed the RMS that three additional *in vitro* studies (mouse lymphoma and human lymphocytes micronucleus) with asulam‐sodium technical or asulam technical were available (data gap)[5](#efs25251-note-1005){ref-type="fn"} but were not eligible for the peer review. Overall, a slight majority of experts agreed that based on the weight of evidence asulam and asulam‐sodium are unlikely to be genotoxic.

The substance showed no carcinogenic potential in rats and mice. With regard to reproductive toxicity, no effects were observed in the offspring, whereas a reduced litter size was observed in the first generation in the absence of maternal toxicity. As a consequence, the parental NOAEL of 224 mg/kg bw per day and the reproductive NOAEL of 46 mg/kg bw per day was agreed. With regard to foetal development, no teratogenic effect was observed but only a delayed/reduced ossification in the rat foetuses at 2,000 mg/kg bw per day.

In rats, mice and dogs, repeated dose studies did not show any evidence of cholinesterase inhibition and no further neurotoxicity studies were required.

Asulam is not classified or proposed to be classified as toxic for reproduction category 2 or carcinogenic category 2, in accordance with the provisions of Regulation (EC) No 1272/2008[10](#efs25251-note-1010){ref-type="fn"}, and therefore, the conditions of the interim provisions of Annex II, Point 3.6.5 of Regulation (EC) No 1107/2009 concerning human health for the consideration of endocrine disrupting properties are not met. With regard to the scientific risk assessment, the relevance to human of the thyroid toxicity in dogs was discussed by the experts. The dog is the more sensitive species for thyroid effects, where the NOAEL is based on thyroid toxicity; however, the NOAEL is triggered by other effects in the rat. The mode of action is unknown for asulam and no mechanistic data are available. A data gap on the mode of action for thyroid toxicity was agreed by the majority of the experts, since mechanistic data are missing. The data gap is mainly relevant for hazard identification. *In vitro* studies might be used to investigate the mode of action of asulam. The RMS did not agree with the data gap. During the peer review, the applicant informed the RMS that an additional developmental thyroid toxicity study in rats is available but it cannot be taken into account during the peer review process.[5](#efs25251-note-1005){ref-type="fn"}

The agreed acceptable daily intake (ADI) is 0.36 mg/kg bw per day based on the 2‐year rat study, the acceptable operator exposure level (AOEL) is 0.46 mg/kg bw per day based on the rat multigeneration study, and the acute reference dose (ARfD) is 1.0 mg/kg bw based on the 12‐month dog study. All reference values were derived applying a uncertainty factor of 100, and no correction was made for oral absorption when setting the AOEL.

**Non‐dietary exposure** (i.e. operator, worker, bystander and resident) are below the AOEL even without the use of personal protective equipment for operators (German Model and UK POEM) and workers.

The toxicological profile of the **metabolite** sulfanilamide appears to be qualitatively similar to asulam. Quantitatively it appears of higher toxicity than asulam. However, it is not possible to properly estimate differences on potency between the compounds and specific reference values were set. The majority of experts agreed to set a specific ADI of 0.005 mg/kg bw per day based on the NOAEL of 30 mg/kg bw per day (uncertainty factor (UF) of 6,000 to take into account exposure duration and lack of reproductive toxicity studies). One MS and the RMS disagreed. The experts at the meeting did not discuss the ARfD. EFSA recommends to follow the same approach as discussed during the meeting for the ADI, i.e. considering the lack of reproductive toxicity studies, the resulting ARfD would be 0.03 mg/kg bw (NOAEL of 30 mg/kg bw per day in 28‐day study, UF of 1,000 to take into account the lack of reproductive toxicity studies), as reflected by the RMS revisions made post Experts\' meetings. The experts agreed that reference values of asulam also apply to metabolites malonyl‐asulam, acetyl asulam, formyl asulam, asulam glucoside and desamino asulam. The experts agreed that reference values of sulfanilamide also apply to metabolites malonyl sulfanilamide, 4‐acetylbenzene sulfonamide, sulfanilic acid and acetyl sulfanilamide. No conclusion could be drawn regarding asulam dimer 1 and 2 since the precise structure is unknown.

3. Residues {#efs25251-sec-0008}
===========

Asulam was discussed at the Pesticide Peer Review experts\' meeting 158 and Peer Review Teleconference 162b.

The assessment in the residue section is based on the guidance documents listed in the document 1607/VI/97 rev.2 (European Commission, [1999](#efs25251-bib-0007){ref-type="ref"}), the European Commission guideline document on MRL setting (European Commission, [2011](#efs25251-bib-0014){ref-type="ref"}), the JMPR recommendations on livestock burden calculations (JMPR, [2004](#efs25251-bib-0021){ref-type="ref"}, [2007](#efs25251-bib-0022){ref-type="ref"}) and OECD publication on MRL calculations (OECD, [2011](#efs25251-bib-0023){ref-type="ref"}).

Metabolism was investigated in spinach following soil application (pre‐emergence) and foliar application (post‐emergence), and in ryegrass upon foliar application.

In spinach, asulam and malonyl asulam were found to be the predominant compounds of the total residues following pre‐emergence (45--56% total radioactive residue (TRR)) and post‐emergence (73.6--96.4% TRR) applications. Other compounds occurred at lower proportions (asulam glucoside 26% TRR, acetyl asulam 8% TRR and desamino asulam 14% of TRR). Acetyl sulfanilamide was found in the pre‐emergence spinach samples and was recovered together with sulfanilamide in the spinach residue field trials at short preharvest intervals (PHIs) (up to 7 days). The study on rye grass showed a steady decrease of the proportion of free asulam over the course of time (from initially 60% TRR to 22% TRR) coupled with an increase of proportions of its hexose/pentose conjugates. Acetyl asulam and desamino asulam occurred at 17% and 14% TRR, respectively.

As for the higher potency of sulfanilamide compared to asulam (see Section [2](#efs25251-sec-0007){ref-type="sec"}), sulfanilamide is a relevant metabolite. The reference values of sulfanilamide cover also acetyl sulfanilamide and malonyl sulfanilamide.

On basis of the available data and information, the residue definition for risk assessment for leafy crops was set as (1) sum of asulam, malonyl asulam and sugar conjugates of asulam expressed as asulam and (2) sulfanilamide, to be considered separately. For monitoring, the residue definition is proposed as sum of asulam and malonyl asulam expressed as asulam. The metabolism data on ryegrass was not considered sufficient to fully address metabolism for the cereals/grass crop category as residues in cereal grains were not investigated.

Due to flaws in the available study, the assessment of residues in rotational crops and the residue definition could not be concluded; therefore, a data gap was identified for a rotational crop metabolism study to be conducted in compliance with current recommendations. When appropriately designed, such a study should cover the issue of soil unextractable residues, as discussed in Section [4](#efs25251-sec-0009){ref-type="sec"}. The available study indicated significant total residue levels in all edible parts of the tested rotational crops (spinach, wheat and radish).

A study simulating industrial and household food processing demonstrated that asulam degrades with significant formation of sulfanilamide under all of the representative conditions (23% applied radioactivity (AR) at pasteurisation, 62% at baking/boiling and 49% at sterilisation) and that malonyl asulam degrades into malonyl sulfanilamide (7%, 26% and 27%, respectively). Taking into account in addition the higher relative toxicity of sulfanilamide and malonyl sulfanilamide, the residue definition for risk assessment for processed commodities is set as (1) sum of asulam, malonyl asulam and sugar conjugates of asulam expressed as asulam and (2) sum of sulfanilamide and malonyl‐sulfanilamide expressed as sulfanilamide. The residue definition for monitoring is proposed as sum of asulam and malonyl‐asulam expressed as asulam.

With regard to the primary crop spinach, a livestock assessment is not triggered. Whether livestock exposure would be significant in terms of relevant metabolite residues in rotational crops cannot be concluded due to a data gap. It remains therefore open whether the available livestock metabolism studies in goat and hen are fully appropriate to address the residue situation with regard to residues in feed items. The animal studies were conducted only with asulam and it cannot be excluded that additional metabolites, not covered by the available studies, may become main drivers for livestock exposure. The residue definitions in animal commodities were therefore derived on a tentative basis for risk assessment as (1) asulam and (2) acetyl sulfanilamide expressed as sulfanilamide and for monitoring as asulam.

A sufficient number of valid residue trials support the critical GAP (cGAP) in spinach (northern Europe (NEU), post‐emergence application) and permit derivation of input values for monitoring/MRL setting. The highly variable residues in spinach across the range of residues trials are noted. However, the number of trials for consumer dietary exposure assessment in line with the residue definitions for risk assessment and at the requested PHI is only four, and on this basis, a median conversion factor was derived and applied to complete the risk assessment. In addition, two processing trials with spinach out of four were considered appropriate to derive processing yield factors taking account of the formation of residues of higher toxicity during processing. As these processing factors are not considered very robust, and in order to refine the risk assessment further, an additional processing residue trial is required (data gap).

To confirm integrity of residues until final analysis of all samples in the residue field trials and processing trials information on the volatility and reactivity of sulfanilamide, malonyl sulfanilamide and acetyl sulfanilamide is required (data gap).

Two separate consumer risk assessments were conducted for the sum of asulam, malonyl asulam and sugar conjugates of asulam expressed as asulam, and for the sum of sulfanilamide and malonyl‐sulfanilamide expressed as sulfanilamide, taking account of the formation of residues of higher potency during food processing.

For the sum of asulam, malonyl asulam and sugar conjugates of asulam expressed as asulam the theoretical maximum daily intake (TMDI), calculated with the MRL reaches a maximum of 5.9% of the ADI of 0.36 mg/kg bw per day. The international estimated short‐term intake (IESTI) reaches a maximum of 54% of the ARfD of 1.0 mg/kg bw for fresh spinach, and 32.5% of the ARfD for processed spinach.

For the sum of sulfanilamide and malonyl‐sulfanilamide expressed as sulfanilamide, the international estimated daily intake (IEDI) was less than 1% of the ADI of 0.005 mg/kg bw per day, and the IESTI reaches a maximum of 94.2% of the ARfD 0.03 mg/kg bw for processed spinach. The assessment for sulfanilamide and related residues is provisional and surrounded by high uncertainty due to limitations in the derivation of robust processing yield factors from the available processing studies. The assessment may overestimate actual consumer exposure to sulfanilamide and related residues from processed spinach, but the degree of overestimation is currently unknown. The assumptions on which the calculation has been based should be verified by additional data in processed spinach commodities, specifically by investigating the role of asulam glucosides (much higher levels than free asulam in the raw agricultural commoditie (RAC)) in the formation of sulfanilamide related residues, which is not addressed by the current submission. Moreover, validation of the residue levels in the available processing trials by information on storage stability is required. It is also noted that potential residues in rotational crops have not been considered due to insufficient data to conclude the assessment in this area, and these residues could be related to the major soil metabolite sulfanilamide (see Section [4](#efs25251-sec-0009){ref-type="sec"}).

EFSA reminds that the separated assessment approach is disregarding the common effects of asulam and sulfanilamide, and their related residues, specifically in view of the conclusion in Section [2](#efs25251-sec-0007){ref-type="sec"} that the toxicological profile of asulam and sulfanilamide appears qualitatively similar but only their potency is different. Thus, considering a combined assessment without further refinement by appropriate processing data, it cannot be currently concluded whether or not intakes may exceed reference values with regard to consumption of processed spinach. Therefore, and in view of the uncertainties reported, the consumer risk assessment cannot be considered finalised for the representative use in spinach. It is noted that the RMS expressed confidence that an exceedance for combined intakes is unlikely.

4. Environmental fate and behaviour {#efs25251-sec-0009}
===================================

The test substance used in most fate and behaviour investigations was asulam‐sodium salt (where concentrations investigated were below its aqueous solubility), but some studies were conducted with asulam. In solution, asulam‐sodium dissociates, with the ionised and unionised forms being in equilibrium, with the proportion of the different forms depending on the pH of the surrounding environment of the compound. In the environment other counter ions, which are present can also form salts with asulam. The rates of dissipation and degradation in the environmental matrices investigated were estimated using FOCUS ([2006](#efs25251-bib-0018){ref-type="ref"}) kinetics guidance. In soil laboratory incubations under aerobic conditions in the dark, asulam exhibited low to moderate persistence, forming the major (\> 10% AR) metabolite sulfanilamide (max. 14% AR) which also exhibited low to moderate persistence. Mineralisation of the phenyl ring ^14^C radiolabel to carbon dioxide accounted for 2.9--7.5% AR after 118--120 days. The formation of unextractable residues (not extracted by acetone/water followed by acidified water and acidified acetonitrile soxhlet reflux) for this radiolabel accounted for 63.9--76.2% AR after 118--120 days. As in some of the soils investigated mineralisation at 100 days was \< 5% AR and unextractable residues were \> 70% AR, the investigation for potential long‐term effects from unextractable residues is triggered and needs to be addressed. This is discussed further in Sections [3](#efs25251-sec-0008){ref-type="sec"} and [5](#efs25251-sec-0010){ref-type="sec"}. In anaerobic soil incubations. Asulam was essentially stable. Asulam exhibited very high to high mobility in soil. Sulfanilamide exhibited high to medium soil mobility. It was concluded that the adsorption of asulam, asulam salts and sulfanilamide was not pH dependent.

In laboratory incubations in dark aerobic natural sediment water systems, asulam exhibited medium persistence. The unextractable sediment fraction (not extracted by acetone/water or methanol) was the major sink for the phenyl ring ^14^C radiolabel, accounting for 45--73% AR at 104--120 days. Mineralisation of this radiolabel accounted for 1.9--11% AR at 90--104 days. The rate of decline of asulam in laboratory sterile aqueous photolysis experiments was quicker than that which occurred in the aerobic sediment water incubations. The major phototransformation products identified were AP formamide (max. 24% AR, pH 9) MCAPAP carbamate (max. 12% AR, pH 9) and sulfanilic acid (max. 55% AR, pH 4). The necessary surface water and sediment exposure assessments (predicted environmental concentrations (PEC) calculations) were carried out for the metabolite sulfanilamide, using the FOCUS ([2001](#efs25251-bib-0017){ref-type="ref"}) step 1 and step 2 approach (version 2.1 of the Steps 1--2 in FOCUS calculator). For the substance asulam and the aqueous phototransformation products, appropriate step 3 (FOCUS, [2001](#efs25251-bib-0017){ref-type="ref"}) and step 4 calculations were available where the FOCUS surface water crop leafy vegetables was used in simulations as a surrogate for spinach and flower bulbs.[11](#efs25251-note-2010){ref-type="fn"} The step 4 calculations appropriately followed the FOCUS ([2007](#efs25251-bib-0019){ref-type="ref"}) guidance, with no‐spray drift buffer zones of up to 5 m being implemented for the drainage scenarios (representing a 13.5--72.9% spray drift reduction), and no‐spray buffer zones up to 5 m (also 13.5--72.9% spray drift reduction) combined with vegetative buffer strips of up to 20 m (reducing solute flux in run‐off by 80% and erosion runoff of mass adsorbed to soil by 95%) being implemented for the run‐off scenarios. The SWAN tool (version 1.1.4) was appropriately used to implement these mitigation measures in the simulations. However, risk managers and others may wish to note that while run‐off mitigation is included in the step 4 calculations available, the FOCUS (FOCUS, [2007](#efs25251-bib-0019){ref-type="ref"}) report acknowledges that for substances with K~Foc~ \< 2,000 mL/g (i.e. asulam), the general applicability and effectiveness of run‐off mitigation measures had been less clearly demonstrated in the available scientific literature, than for more strongly adsorbed compounds.

The necessary groundwater exposure assessments were appropriately carried out using FOCUS ([2009](#efs25251-bib-0020){ref-type="ref"}) scenarios and the models PEARL 4.4.4 and PELMO 4.4.3[12](#efs25251-note-1011){ref-type="fn"} for the substance asulam and its soil metabolite sulfanilamide where the FOCUS groundwater crop cabbage was used in simulations as a surrogate for spinach and flower bulbs. The potential for groundwater exposure from the representative uses by asulam and its salts and sulfanilamide above the parametric drinking water limit of 0.1 μg/L was concluded to be low in geoclimatic situations that are represented by all 7 FOCUS groundwater scenarios defined for the FOCUS crop cabbage.

The applicant did not provide appropriate information to address the effect of water treatments processes on the nature of the residues that might be present in surface water, when surface water is abstracted for drinking water. This has led to the identification of a data gap (see Section [7](#efs25251-sec-0012){ref-type="sec"}) and results in the consumer risk assessment not being finalised (see Section [9](#efs25251-sec-0014){ref-type="sec"}).

The PEC for asulam and its metabolites in soil, surface water, sediment and groundwater covering the representative uses assessed can be found in Appendix [A](#efs25251-sec-1002){ref-type="sec"} of this conclusion.

5. Ecotoxicology {#efs25251-sec-0010}
================

The following documents were considered for the risk assessment: European Commission ([2002a](#efs25251-bib-0010){ref-type="ref"},[b](#efs25251-bib-0011){ref-type="ref"}), SETAC ([2001](#efs25251-bib-0024){ref-type="ref"}) and EFSA ([2009](#efs25251-bib-0003){ref-type="ref"}).

Some aspects of the risk assessment of asulam were discussed at the Pesticide Peer Review meeting 157 (April 2017).

A low acute risk to **birds** and **wild mammals** to asulam was concluded for both representative uses. However, the long‐term risk for the representative uses to birds and mammals was indicated as high for all generic focal species at tier‐1 risk assessment with the exception of small insectivorous mammals. Therefore, a number of refinement options were proposed (e.g. residue decline in plants, ecological information of selected species, data on body weight and food consumption of common voles). However, the data available for the refinement options were not considered suitable to be used in quantitative risk assessments. In addition, qualitative arguments (i.e. weight of evidence) were also provided for the risk assessments for small herbivorous mammals. The RMS did not conclude on a low risk for the representative uses of asulam, nor was it supported during the peer‐review. Since the high risk identified with the tier‐1 risk assessments could not be addressed, a data gap was identified for further information to address the long‐term risk to birds and wild mammals (this issue is a critical area of concern).

A low risk to birds and mammals via secondary poisoning and via consumption of contaminated drinking water was concluded.

As regards **aquatic organisms**, a low risk for asulam was concluded for both representative uses up to FOCUS Step 3 level for fish, aquatic invertebrates and algae. However, the risk for aquatic plants was indicated as high for the majority of the FOCUS scenarios (at FOCUS step 3). Therefore, FOCUS step 4 PEC~sw~ were calculated considering a 5‐m no‐spray buffer zone and 80% run‐off mitigation (i.e. considering vegetative filter strips). The risk assessment at FOCUS step 4 indicated a low risk for all the relevant scenarios except for FOCUS R4 for the representative use on spinach (data gap).

A low risk to metabolite sulfanilamide was concluded considering the available toxicity endpoints for algae and aquatic plants for both representative uses. No toxicity data were available for the photolytic metabolites (AP formamide, MCAPAP carbamate, sulfanilic acid) with the exception of an endpoint for aquatic plants for sulfanilic acid. However, screening assessments by assuming that these metabolites are ten times more toxic to aquatic organisms than asulam were conducted. When a risk mitigation of a 5‐m no‐spray buffer zone and 80% run‐off mitigation was considered (i.e. FOCUS step 4), a low risk was concluded for these metabolites for both representative uses.

A low risk to **bees** was concluded on the basis of the available acute oral and acute contact toxicity endpoints for both representative uses. It is noted that no additional data for bees (e.g. chronic toxicity data) were available as no additional data is required by the regulation applicable for asulam.

Based on the available laboratory data, a low risk to **non‐target arthropods** was concluded for both representative uses. Also, a low risk for asulam and for sulfanilamide was concluded for **soil macro‐** and **microorganisms** for both representative uses on the basis of the available laboratory data. However, long‐term studies (e.g. field studies) investigating the long‐term effects of non‐extractable residues were not available, although this assessment is triggered by the available fate and behaviour information (see Section [4](#efs25251-sec-0009){ref-type="sec"}). A data gap was identified to address this issue.

A regards **non‐target terrestrial plants**, a low risk was demonstrated by a higher tier probabilistic risk assessment and considering a risk mitigation measure a 5‐m no‐spray buffer zone (or any risk mitigation measure with equivalent effectivity to a 5‐m no‐spray buffer zone).

A low risk for **biological methods of sewage treatment** was concluded for the uses of asulam.

For the ecotoxicological assessments, no specific studies were available to address the potential **endocrine activity** of asulam. Pending on the outcome of the data gap in Section [2](#efs25251-sec-0007){ref-type="sec"}, further ecotoxicological tests might be necessary to address the potential endocrine disrupting properties of asulam.

6. Overview of the risk assessment of compounds listed in residue definitions triggering assessment of effects data for the environmental compartments (Tables [1](#efs25251-tbl-0001){ref-type="table"}, [2](#efs25251-tbl-0002){ref-type="table"}, [3](#efs25251-tbl-0003){ref-type="table"}, [4](#efs25251-tbl-0004){ref-type="table"}) {#efs25251-sec-0011}
==========================================================================================================================================================================================================================================================================================================================================

###### 

Soil

+-----------------------------+-----------------------------------------------------------------------------------------------------------+----------------------------+
| Compound (name and/or code) | Persistence                                                                                               | Ecotoxicology              |
+=============================+===========================================================================================================+============================+
| Asulam and its salts        | Low to moderate persistence                                                                               | Data gap                   |
|                             |                                                                                                           |                            |
|                             | Single first‐order and biphasic kinetics DT~50~ 0.2--11.2 days (DT~90~ 7.1--37.2 days, 20°C 45--93% MWHC) |                            |
+-----------------------------+-----------------------------------------------------------------------------------------------------------+----------------------------+
| Sulfanilamide               | Low to moderate persistence                                                                               | Low risk to soil organisms |
|                             |                                                                                                           |                            |
|                             | Biphasic kinetics DT~50~ 1.4--7.7 days (DT~90~ 10.3--149 days, 20°C 42--90% MWHC)                         |                            |
+-----------------------------+-----------------------------------------------------------------------------------------------------------+----------------------------+

DT~50~: period required for 50% dissipation; DT~90~: period required for 90% dissipation; MWHC: maximum water‐holding capacity.

John Wiley & Sons, Ltd

###### 

Groundwater

+-----------------------------+----------------------------+---------------------------------------------------------------------------------------------+--------------------------+--------------------------+
| Compound (name and/or code) | Mobility in soil           | \> 0.1 μg/L at 1 m depth for the representative uses[a](#efs25251-note-0006){ref-type="fn"} | Pesticidal activity      | Toxicological relevance  |
+=============================+============================+=============================================================================================+==========================+==========================+
| Asulam and its salts        | Very high to high mobility | No                                                                                          | Yes                      | Yes                      |
|                             |                            |                                                                                             |                          |                          |
|                             | K~Foc~ 15--66 mL/g         |                                                                                             |                          |                          |
+-----------------------------+----------------------------+---------------------------------------------------------------------------------------------+--------------------------+--------------------------+
| Sulfanilamide               | High to medium mobility    | No                                                                                          | Assessment not triggered | Assessment not triggered |
|                             |                            |                                                                                             |                          |                          |
|                             | K~Foc~ 96--278 mL/g        |                                                                                             |                          |                          |
+-----------------------------+----------------------------+---------------------------------------------------------------------------------------------+--------------------------+--------------------------+

K~Foc~: Freundlich organic carbon adsorption coefficient.

At least one FOCUS scenario or a relevant lysimeter.

John Wiley & Sons, Ltd

###### 

Surface water and sediment

  Compound (name and/or code)   Ecotoxicology
  ----------------------------- ----------------------------------------------------------------------------------------------------------------------
  Asulam and its salts          Low risk to aquatic organisms with risk mitigation for all, but one FOCUS scenarios (data gap for R4 FOCUS scenario)
  Sulfanilamide                 Low risk to aquatic organisms
  Sulfanilic acid               Low risk to aquatic organisms with risk mitigation
  AP formamide                  Low risk to aquatic organisms with risk mitigation
  MCAPAP carbamate              Low risk to aquatic organisms with risk mitigation

FOCUS: Forum for the Co‐ordination of Pesticide Fate Models and their Use.

John Wiley & Sons, Ltd

###### 

Air

  Compound (name and/or code)   Toxicology
  ----------------------------- ----------------------------------------------------------------------------
  Asulam                        Low acute inhalation toxicity to rats (Rat LC~50~ inhalation \> 5.46 mg/L)

LC~50~: lethal concentration, 50%.

John Wiley & Sons, Ltd

7. Data gaps {#efs25251-sec-0012}
============

This is a list of data gaps identified during the peer review process, including those areas in which a study may have been made available during the peer review process but not considered for procedural reasons (without prejudice to the provisions of Article 56 of the Regulation concerning information on potentially harmful effects). Revalidation of the method proposed as the monitoring method for the four crop groups using three extraction steps (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Section [1](#efs25251-sec-0006){ref-type="sec"}).Revalidation of the ILV for the monitoring method for plants (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Section [1](#efs25251-sec-0006){ref-type="sec"}).Mechanistic data investigating whether the mode of action for thyroid toxicity is endocrine‐mediated (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Section [2](#efs25251-sec-0007){ref-type="sec"}).Toxicity studies submitted to United States Environmental Protection Agency (US EPA) including genotoxicity, developmental thyroid toxicity and dermal toxicity studies (relevant for all representative uses evaluated; submission date proposed by the applicant: done; see Section [2](#efs25251-sec-0007){ref-type="sec"}).At least one additional processing residue trial in spinach with sufficiently high initial residue levels in the RAC and analysing for all relevant compounds (malonyl asulam, malonyl sulfanilamide, free and conjugated residues of asulam and sulfanilamide), in accordance with current requirements and guidelines. With this experiment it should also be demonstrated whether sulfanilamide glucosides could be formed from asulam glucosides or whether complete hydrolysis into sulfanilamide occurs (relevant for representative uses in spinach; submission date proposed by the applicant: unknown; see Section [3](#efs25251-sec-0008){ref-type="sec"})Information on the volatility and reactivity of sulfanilamide, malonyl sulfanilamide and acetyl sulfanilamide in order to conclude whether storage stability data on these compounds can be omitted or are required to confirm integrity of residues until final analysis of all samples in the residue field and processing trials (relevant for representative uses in spinach; submission date proposed by the applicant: unknown; see Section [3](#efs25251-sec-0008){ref-type="sec"}).A nature‐of‐residues study in rotational crops, compliant with current recommendations (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Section [3](#efs25251-sec-0008){ref-type="sec"})Satisfactory information to address the unless clause of the uniform principles 2.5.1.1 to demonstrate that under field conditions there is no accumulation in soil at such levels that unacceptable residues in succeeding crops occur was not available considering the data gap regarding the available information on the nature of residues in following crops (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Sections [3](#efs25251-sec-0008){ref-type="sec"} and [4](#efs25251-sec-0009){ref-type="sec"}).Satisfactory information to address the unless clause of the uniform principles 2.5.1.1 to demonstrate that under field conditions there is no accumulation in soil at such levels that unacceptable impact on the environment would not occur, was not available (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Section [4](#efs25251-sec-0009){ref-type="sec"}).Satisfactory information to address the effect of water treatment processes on the nature of residues in surface water, when surface water is abstracted for drinking water was not available. Probably in the first instance, a consideration of the processes of ozonation and chlorination would appear appropriate. If an argumentation is made that concentrations at the point of abstraction for drinking water purposes will be low, this argumentation should cover metabolites predicted to be in surface water, as well as the active substance. Should this consideration indicate that novel compounds might be expected to be formed from water treatment, the risk to human or animal health through the consumption of drinking water containing them should be addressed (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Section [4](#efs25251-sec-0009){ref-type="sec"}).Satisfactory information to address the long‐term risk to birds and wild mammals (relevant for all representative uses evaluated; submission date proposed by the applicant: further data had already been submitted to the RMS; see Section [5](#efs25251-sec-0010){ref-type="sec"}).Satisfactory information to address the risk to aquatic organisms for geoclimatic situations represented by R4 FOCUS surface water scenario (relevant for the representative use on spinach; submission date proposed by the applicant: unknown; see Section [5](#efs25251-sec-0010){ref-type="sec"}).Satisfactory information to address the long‐term risk to soil organisms from non‐extractable soil residues (relevant for all representative uses evaluated; submission date proposed by the applicant: unknown; see Section [5](#efs25251-sec-0010){ref-type="sec"}).

8. Particular conditions proposed to be taken into account to manage the risk(s) identified {#efs25251-sec-0013}
===========================================================================================

In order to ensure in a low risk to aquatic organisms, risk mitigation measures with equivalent effectivity to a 5‐m no‐spray buffer zone and 80% run‐off mitigation should be taken into account for geoclimatic situations represented by D3, D6, R2, R3 FOCUS surface water scenarios for the uses on spinach and flower bulbs. In addition, risk mitigation measure with equivalent effectivity would be needed for the R1 scenario for the use on flower bulbs (see Section [5](#efs25251-sec-0010){ref-type="sec"}).In order to ensure in a low risk to non‐target terrestrial plants, risk mitigation measures with equivalent effectivity to a 5‐m no‐spray buffer zone should be taken into account (see Section [5](#efs25251-sec-0010){ref-type="sec"}).

9. Concerns {#efs25251-sec-0014}
===========

9.1. Issues that could not be finalised {#efs25251-sec-0015}
---------------------------------------

An issue is listed as 'could not be finalised' if there is not enough information available to perform an assessment, even at the lowest tier level, for the representative uses in line with the uniform principles in accordance with Article 29(6) of the Regulation and as set out in Commission Regulation (EU) No 546/2011[12](#efs25251-note-1011){ref-type="fn"} and if the issue is of such importance that it could, when finalised, become a concern (which would also be listed as a critical area of concern if it is of relevance to all representative uses).

An issue is also listed as 'could not be finalised' if the available information is considered insufficient to conclude on whether the active substance can be expected to meet the approval criteria provided for in Article 4 of the Regulation. The thyroid toxicity could be potentially linked to an endocrine mode of action (see Section [2](#efs25251-sec-0007){ref-type="sec"}).The consumer exposure assessment for sulfanilamide metabolites is highly uncertain and is leading to provisional estimates of acute consumer exposure close to the ARfD for the use in spinach. When considering the presumed qualitatively similar toxicological profile of asulam and sulfanilamide but their different potency, it cannot be currently concluded whether or not a combined assessment may result in exceedance of the acute reference values with regard to processed spinach consumption while a refined consumer risk assessment cannot be finalised (see Section [3](#efs25251-sec-0008){ref-type="sec"}).The consumer risk assessment from the consumption of drinking water could not be finalised, while satisfactory information was not available to address the effect of water treatment processes on the nature of the residues that might be present in surface water, when surface water is abstracted for drinking water (see Section [4](#efs25251-sec-0009){ref-type="sec"}).The long‐term risk to soil organisms from non‐extractable soil residues could not be finalised (see Section [5](#efs25251-sec-0010){ref-type="sec"}).

9.2. Critical areas of concern {#efs25251-sec-0016}
------------------------------

An issue is listed as a critical area of concern if there is enough information available to perform an assessment for the representative uses in line with the uniform principles in accordance with Article 29(6) of the Regulation and as set out in Commission Regulation (EU) No 546/2011, and if this assessment does not permit the conclusion that, for at least one of the representative uses, it may be expected that a plant protection product containing the active substance will not have any harmful effect on human or animal health or on groundwater or any unacceptable influence on the environment.

An issue is also listed as a critical area of concern if the assessment at a higher tier level could not be finalised due to lack of information, and if the assessment performed at the lower tier level does not permit the conclusion that, for at least one of the representative uses, it may be expected that a plant protection product containing the active substance will not have any harmful effect on human or animal health or on groundwater or any unacceptable influence on the environment.

An issue is also listed as a critical area of concern if, in the light of current scientific and technical knowledge using guidance documents available at the time of application, the active substance is not expected to meet the approval criteria provided for in Article 4 of the Regulation. The long‐term risk to birds and wild mammals was assessed as high (see Section [5](#efs25251-sec-0010){ref-type="sec"}).

9.3. Overview of the concerns identified for each representative use considered {#efs25251-sec-0017}
-------------------------------------------------------------------------------

(If a particular condition proposed to be taken into account to manage an identified risk, as listed in Section [8](#efs25251-sec-0013){ref-type="sec"}, has been evaluated as being effective, then 'risk identified' is not indicated in Table [5](#efs25251-tbl-0005){ref-type="table"}.)

###### 

Overview of concerns

  Representative use                                                            Spinach                                                                  Tulip hyacinth and lily (bulb production)   
  ----------------------------------------------------------------------------- ------------------------------------------------------------------------ ------------------------------------------- ------
  **Operator risk**                                                             Risk identified                                                                                                      
  Assessment not finalised                                                                                                                                                                           
  **Worker risk**                                                               Risk identified                                                                                                      
  Assessment not finalised                                                                                                                                                                           
  **Resident/bystander risk**                                                   Risk identified                                                                                                      
  Assessment not finalised                                                                                                                                                                           
  **Consumer risk**                                                             Risk identified                                                                                                      
  Assessment not finalised                                                      X^2,3^                                                                   X^3^                                        
  **Risk to wild non‐target terrestrial vertebrates**                           Risk identified                                                          X^5^                                        X^5^
  Assessment not finalised                                                                                                                                                                           
  **Risk to wild non‐target terrestrial organisms other than vertebrates**      Risk identified                                                                                                      
  Assessment not finalised                                                      X^4^                                                                     X^4^                                        
  **Risk to aquatic organisms**                                                 Risk identified                                                          1/7 FOCUS scenarios                         
  Assessment not finalised                                                                                                                                                                           
  **Groundwater exposure to active substance**                                  Legal parametric value breached                                                                                      
  Assessment not finalised                                                                                                                                                                           
  **Groundwater exposure to metabolites**                                       Legal parametric value breached[a](#efs25251-note-0010){ref-type="fn"}                                               
  Parametric value of 10 μg/L[b](#efs25251-note-0011){ref-type="fn"} breached                                                                                                                        
  Assessment not finalised                                                                                                                                                                           

Columns are grey if no safe use can be identified. The superscript numbers relate to the numbered points indicated in Sections [9.1](#efs25251-sec-0015){ref-type="sec"} and [9.2](#efs25251-sec-0016){ref-type="sec"}. Where there is no superscript number, see Sections [2](#efs25251-sec-0007){ref-type="sec"}--[6](#efs25251-sec-0011){ref-type="sec"} for further information.

It should be noted that the classification proposed in the context of this evaluation procedure under Regulation (EC) No 1107/2009 concurs with the harmonised classification and labelling in accordance with Regulation (EC) No 1272/2008.

Value for non‐relevant metabolites prescribed in SANCO/221/2000‐rev. 10 final, European Commission, [2003](#efs25251-bib-0012){ref-type="ref"}.

John Wiley & Sons, Ltd

Abbreviations {#efs25251-sec-0018}
=============

a.s.active substanceADIacceptable daily intakeAOELacceptable operator exposure levelARapplied radioactivityARfDacute reference dosebwbody weightcGAPcritical Good Agricultural PracticeCLPclassification, labelling and packagingDARdraft assessment reportDT~50~period required for 50% dissipation (define method of estimation)DT~90~period required for 90% dissipation (define method of estimation)ECHAEuropean Chemicals AgencyEECEuropean Economic CommunityEPAEnvironmental Protection AgencyFAOFood and Agriculture Organization of the United NationsFOCUSForum for the Co‐ordination of Pesticide Fate Models and their UseGAPGood Agricultural PracticeIEDIinternational estimated daily intakeIESTIinternational estimated short‐term intakeILVindependent laboratory validationi.p.intraperitonealISOInternational Organization for StandardizationIUPACInternational Union of Pure and Applied ChemistryJMPRJoint Meeting on the FAO Panel of Experts on Pesticide Residues in Food and the Environment and the WHO Expert Group on Pesticide Residues (Joint Meeting on Pesticide Residues)K~Foc~Freundlich organic carbon adsorption coefficientLC~50~lethal concentration, medianLC‐MS/MSliquid chromatography with tandem mass spectrometryLOQlimit of quantificationMRLmaximum residue levelMWHCmaximum water‐holding capacityNEUnorthern EuropeNOAELno observed adverse effect levelOECDOrganisation for Economic Co‐operation and DevelopmentPECpredicted environmental concentrationPEC~air~predicted environmental concentration in airPEC~gw~predicted environmental concentration in groundwaterPEC~sed~predicted environmental concentration in sedimentPEC~soil~predicted environmental concentration in soilPEC~sw~predicted environmental concentration in surface waterPHIpreharvest intervalPOEMPredictive Operator Exposure ModelRACraw agricultural commoditiesRMSrapporteur Member StateSLsoluble concentrateSMILESsimplified molecular‐input line‐entry systemTCtechnical materialTKtechnical concentrateTMDItheoretical maximum daily intakeTRRtotal radioactive residueUFuncertainty factorWHOWorld Health Organization

Appendix A -- List of end points for the active substance and the representative formulation {#efs25251-sec-1002}
============================================================================================

 {#efs25251-sec-0019}

Appendix [A](#efs25251-sec-1002){ref-type="sec"} can be found in the online version of this output ('Supporting information' section): <https://doi.org/10.2903/j.efsa.2018.5251>

Appendix B -- Used compound codes {#efs25251-sec-1003}
=================================

 {#efs25251-sec-0020}
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Appendix A -- List of end points for the active substance and the representative formulation

###### 

Click here for additional data file.
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